New drug JBZ-001 enters first human trial for Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial is testing a new oral drug called JBZ-001 in 25 adults with advanced solid tumors or certain blood cancers (like lymphoma) that have not responded to standard treatments. The drug works by blocking a protein cancer cells need to grow. The main goals are to …
Phase: PHASE1 • Sponsor: Jabez Bioscience, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC